Zenas BioPharma, Inc. (ZBIO)
21.76
+0.71
(+3.37%)
USD |
NASDAQ |
Apr 16, 16:00
21.74
-0.02
(-0.09%)
After-Hours: 20:00
Zenas BioPharma Total Liabilities (Quarterly) : 141.50M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 156.03M |
| AnaptysBio, Inc. | 327.18M |
| Gilead Sciences, Inc. | 36.40B |
| Nkarta, Inc. | 104.97M |
| Cullinan Therapeutics, Inc. | 40.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.64M |
| Shareholders Equity (Quarterly) | 242.14M |
| Debt to Equity Ratio | 0.3302 |
| Current Ratio | 5.605 |
| Net Debt Paydown Yield | -0.80% |